Psychiatry - Addictions Interview Questions & Answers

← All NHS Medical and Dental interview questions

About this NHS interview question bank

To prepare for an addictions psychiatry NHS interview, expect questions on safe opioid substitution prescribing, alcohol withdrawal and detox planning, dual diagnosis, harm reduction, safeguarding children and adults, and how you work with commissioned third-sector partners. Panels also probe your judgement on DVLA duties, overdose risk after prison or detox, and diversion, so build short spoken answers around real cases and know the UK clinical guidelines on drug misuse, the relevant NICE guidance and GMC Good Medical Practice before you walk in.

This bank contains 40 original practice questions with first-person model answers written for doctors applying for addictions psychiatry posts, pitched mainly at Clinical Fellow and Specialty Doctor level, with a selection aimed at Specialist and Consultant roles. It covers community drug and alcohol services, inpatient detox, prison release, dual diagnosis and partnership working with local authority commissioned providers, and every answer is built around a realistic, non-identifying scenario. Each question explains what the panel is really assessing, the points you must hit, the mistakes to avoid and the guidance worth reading, so you can practise answers that sound like you rather than a textbook.

 

What this question bank covers

• Motivation for addictions psychiatry
• Stigma and NHS values
• Motivational interviewing
• Opioid substitution therapy and safe induction
• Alcohol withdrawal and assisted detox
• Wernicke's encephalopathy and thiamine
• Dual diagnosis
• Harm reduction and naloxone
• Overdose risk after prison or detox
• Pregnancy and substance use
• Safeguarding children and hidden harm
• Adult safeguarding and exploitation
• Prescribing safety and diversion
• DVLA and GMC confidentiality
• Blood-borne virus testing
• Third-sector and commissioned services
• Recovery communities
• Incidents, drug-related deaths and PSIRF
• Leadership from Specialty Doctor to Consultant
• Resilience and wellbeing

 

40 NHS interview questions with full model answers. The first 8 are free to read below. Unlock the remaining 32 for £2.99 (12 months' access).

These are original practice questions written to reflect how NHS interviews are run. They are not leaked or official questions, and Healthcare Interview Prep is independent of the NHS.

 

 

Free NHS interview questions and model answers

 

 

Question 1: Why do you want to work in addictions psychiatry?

Motivation question  ·  Motivation

 

What the interview panel is assessing

The panel wants a genuine, personal reason for choosing a specialty that many doctors avoid. They are listening for an understanding of addiction as a treatable health condition, realism about relapse and slow progress, and signs that you will treat patients without judgement.

 

Model answer

I'll be honest, addictions wasn't on my list when I started psychiatry. What changed my mind was a man I met during a liaison shift in the emergency department. He'd come in after an overdose, and the notes from previous attendances were full of words like 'non-compliant' and 'known drug user'. When I actually sat down with him, he told me he'd been clean for nearly two years before his mother died, and that he'd tried to get back into treatment but the waiting list had put him off. Nobody had asked him about any of that.

I referred him to the community drug service with a proper handover and I happened to see him months later at the same service when I rotated there. He was stable on buprenorphine, had naloxone in his bag and was talking about a volunteering course. He didn't remember me, which was fine. What stayed with me was how much difference a timely, respectful assessment and a safe prescription had made.

That's really the core of why I want this work. It's a specialty where good medicine is genuinely life-saving, because opioid substitution and naloxone reduce deaths, and where the relationship matters as much as the prescription. I like the mix too: pharmacology and prescribing safety, mental health, physical health like liver disease and blood-borne viruses, safeguarding, and working closely with recovery workers, pharmacists and commissioned partners.

I'm also realistic. Relapse is part of the condition for many people, some patients will die despite everyone's efforts, and the stigma our patients face can rub off on the services that treat them. I'd rather be someone who helps change that from the inside, and I think I have the patience and steadiness this job asks for.

 

Why this answer works

The answer opens with a specific, believable moment rather than a cliche, and links it directly to the evidence that treatment saves lives. It shows the breadth of the specialty and is honest about relapse, death and stigma, which reassures the panel that the candidate knows what they are signing up for.

 

Key points to include

• A specific moment that shaped your interest
• Addiction framed as a treatable health condition
• Awareness that OST and naloxone save lives
• The breadth of the work: mental and physical health, safeguarding, partnership
• Realism about relapse, stigma and loss

 

Common mistakes to avoid

• Saying you fell into it because it was the only post available
• Describing patients in judgemental or rescuing language
• Ignoring the physical health and safeguarding side of the role
• Sounding naive about relapse and outcomes

 

NHS values and standards

Compassion; Improving lives; Everyone counts; GMC Good Medical Practice: treat patients fairly and without discrimination

 

Further reading

• GMC Good Medical Practice
• Drug misuse and dependence: UK guidelines on clinical management
• NHS Constitution for England

 

 

Question 2: How does stigma affect people who use drugs and alcohol, and what do you do about it in your own practice?

NHS Values question  ·  Stigma and NHS values

 

What the interview panel is assessing

The panel is checking that you understand stigma as a real barrier to treatment and a contributor to harm, not just a word. They want to hear concrete behaviours, including challenging colleagues kindly, and a link to the NHS values.

 

Model answer

Stigma is one of the biggest reasons people don't come into treatment, or drop out early. People tell me they've been made to wait longer in the emergency department, had their pain dismissed, or been spoken about in the corridor. Some stop asking for help altogether, and that's when the risk of overdose, infection and death goes up. It's also internal. A lot of patients feel deep shame, and shame keeps people using alone, which is exactly when an overdose is most likely to be fatal.

In my own practice I start with language. I write 'a person who uses heroin' rather than 'addict' or 'abuser', and I avoid words like 'clean' and 'dirty' for urine results, because those words follow people through their records. I try to treat a missed appointment as information rather than a moral failing and ask what got in the way.

I also try to challenge it in others, gently. On a medical ward I once overheard a colleague say a patient in withdrawal was 'just drug seeking' and not to bother with his pain. I asked if we could look at it together. He had genuine withdrawal and an abscess, so I suggested we contact the addictions liaison team to confirm his methadone dose with his pharmacy and continue it, and treat his pain properly. My colleague was receptive once it was framed around safety rather than blame.

For me this sits squarely in the NHS values of respect and dignity and everyone counts. People who use drugs have the same right to good care as anyone else, and part of my job is to make the service feel safe enough for them to walk back through the door.

 

Why this answer works

The answer explains how stigma causes harm, gives concrete daily behaviours and includes a respectful challenge to a colleague that ends in safer care. Linking it to the NHS values shows the candidate understands this is a core professional issue.

 

Key points to include

• Stigma delays treatment and increases harm and death
• Person-first, non-judgemental language in speech and records
• Treat disengagement as information, not failure
• Challenge colleagues respectfully, framed around safety
• Link to respect and dignity and everyone counts

 

Common mistakes to avoid

• Talking about stigma only in abstract terms
• Using stigmatising words yourself during the answer
• Criticising colleagues harshly rather than modelling better practice
• Forgetting internalised shame and its link to using alone

 

NHS values and standards

Respect and dignity; Everyone counts; Compassion; GMC Good Medical Practice: treat patients fairly

 

Further reading

• NHS Constitution for England
• GMC Good Medical Practice
• Office for Health Improvement and Disparities guidance on reducing stigma in drug and alcohol treatment

 

 

Question 3: A patient who drinks heavily says they are not sure they want to cut down. How would you use motivational interviewing in that consultation?

Communication question  ·  Motivational interviewing

 

What the interview panel is assessing

The panel wants to see that you understand the spirit of motivational interviewing as well as its techniques. They are looking for curiosity rather than persuasion, an ability to evoke the patient's own reasons for change, and safety checks that still happen within a collaborative conversation.

 

Model answer

The first thing I'd remind myself is that ambivalence is normal. If someone isn't sure, that's actually a good starting point, because part of them is already considering change. My job isn't to argue them into it. If I start listing the dangers of alcohol, the natural reaction is for them to defend their drinking, and then they've talked themselves further away from change.

So I'd begin with open questions. Something like, 'What do you enjoy about drinking?' and then, 'What are the less good things?' Asking about the positives first often surprises people and lowers their guard. I'd use reflections a lot, trying to capture both sides: 'So it helps you switch off after work, and at the same time you're worried about how your partner looks at you in the mornings.' I'd listen out for change talk, anything about desire, ability, reasons or need, and reflect it back so they hear themselves say it.

If they seemed open, I might ask permission before giving information: 'Would it be useful if I shared what your blood results show?' Then I'd ask what they make of it. I might use a scale too: 'On a scale of nought to ten, how important is it for you to change?' If they say four, I'd ask why it's a four and not a two, which draws out their own reasons.

Alongside that I wouldn't skip the clinical safety parts. I'd still ask about morning drinking, previous withdrawal seizures, confusion or hallucinations, because suddenly stopping can be dangerous if someone is dependent. I'd make sure they know not to stop abruptly without advice.

I'd finish with a summary in their own words and agree something small and realistic, even if it's just coming back in two weeks. The relationship is the intervention at that stage, and they should leave feeling heard rather than lectured.

 

Why this answer works

The answer captures the collaborative spirit of motivational interviewing and shows practical skills: open questions, reflections, change talk, asking permission and scaling. Crucially, it keeps alcohol withdrawal safety in view, which panels will look for from a doctor.

 

Key points to include

• Ambivalence is normal and a starting point
• Open questions, reflections, affirmations and summaries
• Evoke change talk rather than persuade
• Ask permission before giving information
• Keep withdrawal risk and safety advice in the conversation
• Agree a small, realistic next step

 

Common mistakes to avoid

• Lecturing about the harms of alcohol
• Labelling the patient as in denial
• Listing techniques without showing the underlying spirit
• Forgetting to warn about the dangers of stopping suddenly if dependent

 

NHS values and standards

Respect and dignity; Compassion; Working together for patients; GMC Good Medical Practice: communicate effectively and support patients in decisions

 

Further reading

• NICE guidance on alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence
• Motivational interviewing: Miller and Rollnick's published framework
• GMC Decision making and consent

 

 

Question 4: A mother on methadone mentions she has a two-year-old at home and recently started using heroin on top again. What would you do?

Safeguarding question  ·  Safeguarding children

 

What the interview panel is assessing

The panel is testing whether you recognise risk to a child while keeping a parent engaged in treatment. They want to hear about safe storage, the child's lived experience, information sharing under Working Together, use of your safeguarding lead, and that substance use alone is not automatically a reason to remove a child.

 

Model answer

First, I'd want to thank her for telling me. That honesty is exactly what we want, and how I respond will shape whether she keeps being honest with us. But the child's safety has to be at the front of my mind, so I'd be clear and kind about that from the start.

I'd want to understand what daily life is like for that two-year-old. Who's at home? Is there another adult, and do they use? When and where is she using, and who's looking after her daughter at those times? Where is the methadone and the heroin kept? A toddler swallowing methadone can be fatal, so I'd ask specifically whether she has a lockable box and whether any take-home doses are kept in the child-resistant bottle. I'd ask about naloxone in the house and whether she's using alone. I'd also ask about her mood, domestic abuse and whether the child is registered with a GP and seeing a health visitor.

Then I'd think about the clinical response. Topping up suggests she might be under-dosed or struggling, so I'd review her prescription and consider moving her back to supervised consumption so fewer doses are at home. I'd make sure she has naloxone and knows how to use it.

On safeguarding, I'd be open with her that I need to share information to keep her daughter safe, ideally with her agreement. I'd discuss it with our safeguarding lead the same day, check whether children's social care or early help are already involved, and contact the health visitor. If I thought the child was at risk of significant harm, I'd make a referral to children's social care even without her consent, and I'd tell her I was doing it unless that would put the child at greater risk.

I'd document clearly what was said, what I observed and my reasoning. Throughout, I'd try to keep her in treatment, because a parent who stays engaged with a safe prescription is usually better for the child than one who disengages.

 

Why this answer works

The answer keeps the child central while treating the mother with respect and keeping her engaged. It covers practical risks such as safe storage and naloxone, clinical changes like supervised consumption, and proper safeguarding steps with the lead, health visitor and children's social care, with clear documentation.

 

Key points to include

• Thank the parent for honesty and stay non-judgemental
• Explore the child's daily experience and who cares for them
• Ask about safe storage, take-home doses and naloxone
• Review prescription, consider supervised consumption
• Involve the safeguarding lead, health visitor and children's social care as needed
• Document reasoning; share information openly where safe

 

Common mistakes to avoid

• Assuming any drug use means immediate removal of the child
• Ignoring the child and focusing only on the adult's treatment
• Delaying action because you don't want to damage rapport
• Forgetting the specific risk of children swallowing methadone

 

NHS values and standards

Everyone counts; Compassion; Working together for patients; GMC Protecting children and young people

 

Further reading

• Working Together to Safeguard Children (England; equivalent guidance in Scotland, Wales and Northern Ireland)
• GMC Protecting children and young people: the responsibilities of all doctors
• Drug misuse and dependence: UK guidelines on clinical management
• Children Act 1989 and 2004

 

 

Question 5: How would you assess and plan an alcohol detox for a patient who wants to stop drinking?

Clinical Scenario question  ·  Alcohol withdrawal and detox planning

 

What the interview panel is assessing

The panel wants to see a structured, safe approach to assisted alcohol withdrawal. They are looking for assessment of dependence and withdrawal risk, the decision between community and inpatient settings, thiamine, planned medication, and a relapse prevention plan rather than detox in isolation.

 

Model answer

I'd start by making sure detox is the right step and that it's planned, not rushed. A detox on its own has poor outcomes unless there's a plan for what comes afterwards, so I'd want to know what support the person has, whether they're linked with a recovery worker, and what they want life to look like after stopping.

Then I'd take a full history. How much, how often, and the pattern across the day, especially morning drinking to relieve shakes. I'd use a validated tool such as the AUDIT for harm and something like the SADQ to judge severity of dependence. The most important questions are about past withdrawals: any seizures, delirium tremens or hallucinations, because those strongly increase risk. I'd ask about other drugs, especially benzodiazepines and opioids, mental health including suicidal thoughts, and physical health such as liver disease, falls and head injuries. I'd examine, check bloods including liver function, clotting and full blood count, and look for signs of Wernicke's encephalopathy or cognitive problems.

With that, I'd decide on setting. A community or home detox can work well for someone with moderate dependence, a stable home, someone who can be with them and no history of complicated withdrawal. I'd think about inpatient detox if there's a history of seizures or delirium tremens, very heavy dependence, significant physical or mental illness, cognitive impairment, polydrug use, or if they're young or vulnerable. NICE gives guidance on these factors, and I'd follow the local protocol.

Medication is usually a reducing course of a long-acting benzodiazepine such as chlordiazepoxide, either fixed-dose in the community or symptom-triggered in a monitored setting using a withdrawal scale like the CIWA-Ar. I'd prescribe thiamine, and parenteral thiamine if they're at high risk of Wernicke's. I'd keep supplies small and arrange daily review in the early days, with clear advice on what to do if they become confused, have a fit or start drinking again on top.

Finally, I'd plan relapse prevention from the start: psychosocial support, mutual aid groups if they're interested, and discussing medications such as acamprosate or naltrexone where suitable.

 

Why this answer works

The answer is structured, clinically accurate and safety-focused. It covers the key risk factors that decide setting, uses recognised tools without over-claiming specific thresholds, includes thiamine and monitoring, and places detox within a wider recovery plan, which is what panels want to hear.

 

Key points to include

• Detox is planned and linked to aftercare
• Assess severity of dependence and history of seizures or DTs
• Screen for other drugs, mental and physical health, cognitive impairment
• Choose community or inpatient setting based on risk
• Benzodiazepine regime, thiamine and close monitoring
• Relapse prevention, psychosocial support and medication options

 

Common mistakes to avoid

• Advising someone dependent to just stop drinking
• Forgetting thiamine or Wernicke's risk
• Giving exact doses or thresholds you aren't sure about
• Treating detox as the end point rather than one step

 

NHS values and standards

Commitment to quality of care; Working together for patients; Improving lives; GMC Good Medical Practice: provide good clinical care

 

Further reading

• NICE guidance on alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence
• NICE guidance on alcohol-use disorders: diagnosis and management of physical complications
• Local trust alcohol withdrawal and detoxification protocol

 

 

Question 6: A patient with alcohol dependence tells you he is still driving to work every day. What are your responsibilities?

Confidentiality question  ·  DVLA and GMC confidentiality

 

What the interview panel is assessing

The panel wants to know you understand the patient's legal duty to inform the DVLA, your duty to advise them, and the GMC process for disclosure in the public interest. They are looking for a balance of confidentiality, public safety and maintaining the therapeutic relationship.

 

Model answer

My first responsibility is to make sure he understands the position clearly. Alcohol dependence and alcohol misuse are conditions that affect fitness to drive, and it's the driver's legal duty, not mine, to tell the DVLA, or the DVA in Northern Ireland. I'd explain that calmly and without making it a threat. I'd also explain the safety side, because a lot of people with dependence don't realise they may still be over the limit the morning after a heavy evening.

I'd advise him not to drive while we're assessing things and to inform the DVLA himself. I'd record that advice clearly in the notes, including that he understood it. If he's lacking capacity to understand the advice, which is unusual but possible with heavy intoxication or cognitive impairment, I'd follow the GMC guidance on that situation, which allows me to inform the DVLA directly.

If he says he'll keep driving, I'd try to understand why. Often it's fear of losing his job. I'd explore alternatives with him, talk about the realistic path back to driving once he's in recovery, and try to persuade him. Sometimes involving a family member, with his consent, helps.

If I later found out he was still driving against advice, the GMC guidance says I should make every reasonable effort to persuade him to stop, and if that fails, disclose relevant information to the DVLA's medical adviser promptly. Before doing that I'd tell him I was going to, and afterwards I'd write to confirm it was done. I'd only share what's relevant to fitness to drive, and I'd discuss it with my consultant or supervisor and document my reasoning.

What I try to keep in mind is that the conversation is part of his care. Handled well, it can actually become a reason to engage with treatment, and I've seen patients use getting their licence back as a real motivator.

 

Why this answer works

The answer accurately sets out that the legal duty sits with the driver, follows the GMC confidentiality guidance step by step, and shows the right sequence of advice, persuasion, telling the patient and then disclosure. It also keeps the therapeutic relationship and public safety in balance.

 

Key points to include

• The driver has the legal duty to inform the DVLA or DVA
• Advise not to drive and document the advice
• Try to persuade and explore barriers
• If they continue driving, disclose to the DVLA medical adviser in line with GMC guidance
• Tell the patient before and confirm after; share only relevant information
• Seek senior advice and document reasoning

 

Common mistakes to avoid

• Saying you would never breach confidentiality
• Phoning the DVLA immediately without advising the patient first
• Sharing the whole history rather than relevant information
• Forgetting to document the advice given

 

NHS values and standards

Everyone counts; Respect and dignity; Commitment to quality of care; GMC Confidentiality: good practice in handling patient information

 

Further reading

• GMC Confidentiality: patients' fitness to drive and reporting concerns to the DVLA or DVA
• DVLA Assessing fitness to drive: a guide for medical professionals
• UK GDPR and Data Protection Act 2018

 

 

Question 7: A man on your caseload is due to be released from prison next week. How would you reduce his risk of overdose?

Patient Safety question  ·  Overdose risk after prison release

 

What the interview panel is assessing

The panel is checking that you know the period after release from prison is one of high risk of fatal overdose and that you can plan for it practically. They want to hear about continuity of treatment, loss of tolerance, naloxone, communication with prison healthcare and the first days in the community.

 

Model answer

The days and weeks after leaving prison are some of the most dangerous for people who use opioids. Tolerance drops in custody, release often comes with stress, housing problems and old contacts, and if someone goes back to using at their old amount, the risk of a fatal overdose is very high. So I'd treat this as a planned transfer of care, not an appointment that happens to fall after release.

First, I'd make contact with the prison healthcare team as early as possible. I'd want to confirm whether he's on opioid substitution therapy, what dose, the date and time of his last supervised dose, and whether there have been any missed doses. I'd also ask about any other prescriptions, especially anything sedating, and his mental health in custody.

Then I'd make sure there's no gap. That means an appointment with us on the day of release or very soon after, a prescription ready at a pharmacy near where he'll be living, and the pharmacy aware he's coming. If he's released on a Friday, I'd plan for the weekend. If he hasn't been on treatment in prison, I'd still want to see him quickly to offer it, because starting treatment soon after release reduces risk.

Naloxone is essential. I'd check whether the prison is supplying it on release and, if not, make sure he gets it from us on day one with training. I'd talk with him honestly about tolerance: that even a small amount could be dangerous, that he shouldn't use alone, and about the current risks in the local supply, such as stronger synthetic opioids.

I'd also link with probation, his recovery worker, housing support and, with his consent, his family, who might also benefit from naloxone training. And I'd document the plan and who's responsible for each part, because gaps between services are where people get lost.

 

Why this answer works

The answer clearly explains why release is high risk, then gives a practical plan covering verification of dose, continuity of prescribing, naloxone and partnership with probation and housing. It shows the candidate thinks across organisational boundaries, which is where safety failures often happen.

 

Key points to include

• Recognise high overdose risk from reduced tolerance after release
• Verify OST dose and last dose with prison healthcare
• No gap in treatment: same or next-day appointment and pharmacy arranged
• Naloxone supply and training on release
• Harm reduction advice: don't use alone, current supply risks
• Link with probation, housing, recovery worker and family

 

Common mistakes to avoid

• Waiting for the man to self-refer after release
• Starting a dose without verifying the last dose from prison
• Forgetting weekend or bank holiday releases
• Not mentioning naloxone

 

NHS values and standards

Commitment to quality of care; Working together for patients; Everyone counts; GMC Good Medical Practice: work collaboratively with colleagues

 

Further reading

• Drug misuse and dependence: UK guidelines on clinical management
• Office for Health Improvement and Disparities guidance on continuity of care for people leaving prison
• Widening the availability of naloxone (UK government guidance)

 

 

Question 8: Talk me through how you would safely start someone on opioid substitution therapy.

Clinical Scenario question  ·  Opioid substitution therapy induction

 

What the interview panel is assessing

The panel wants to see a safe, structured induction that confirms opioid dependence, avoids double prescribing and recognises that the early weeks of methadone treatment carry particular risk. They are also looking for shared decision-making on methadone versus buprenorphine and clear safety advice.

 

Model answer

I'd start with a careful assessment, because the induction period is when people on methadone are at increased risk of overdose, and most of that risk comes from starting too high, increasing too quickly, or someone using other depressants on top.

So first I'd confirm opioid dependence. That's a history of regular use, route and amount, withdrawal symptoms when they don't use, and objective evidence. I'd do a urine or oral fluid drug test and look for signs of withdrawal using a scale like the COWS. I'd check carefully that they're not already being prescribed elsewhere, by contacting their GP, any previous service and, where relevant, prison healthcare.

Then I'd look at other risks: alcohol, benzodiazepines, gabapentinoids, respiratory problems, liver disease, pregnancy, and any history of cardiac problems or medicines that prolong the QT interval, as that's relevant for methadone. I'd ask about previous overdoses and mental health, including suicidal thoughts.

The choice between methadone and buprenorphine is a shared decision. I'd explain the differences honestly: buprenorphine has a better safety profile in overdose and is less sedating, but has to be started when they're in withdrawal to avoid precipitated withdrawal. Methadone can suit people who've struggled with buprenorphine or who need more sedation for comfort. Both are recommended by NICE.

For the induction itself, I'd follow the UK clinical guidelines and our local protocol: start at a cautious dose, titrate gradually with regular review, and usually begin with daily supervised consumption at the pharmacy. I'd explain that the early doses won't fully hold them and that using on top is particularly dangerous during this period.

Every patient leaves with naloxone and knows how to use it. I'd give clear safety advice about not combining with alcohol or other sedatives, safe storage if any doses go home, and what to do if they feel very drowsy. And I'd document everything, including the rationale for the dose and the plan for review.

 

Why this answer works

This is a safe, well-ordered answer that confirms dependence, prevents double prescribing and identifies the specific dangers of methadone induction. It avoids quoting numbers it cannot guarantee, defers to the UK guidelines and local protocol, and includes naloxone and shared decision-making.

 

Key points to include

• Confirm dependence with history, testing and objective withdrawal signs
• Check for prescriptions elsewhere to avoid double prescribing
• Screen for polydrug use, physical risks and QT factors
• Shared decision on methadone or buprenorphine
• Start low, titrate slowly, supervised consumption early on
• Naloxone, safety advice and clear documentation

 

Common mistakes to avoid

• Prescribing on history alone without verification
• Quoting rapid titration schedules or unsafe doses
• Forgetting precipitated withdrawal with buprenorphine
• No mention of naloxone or polydrug risk

 

NHS values and standards

Commitment to quality of care; Working together for patients; Respect and dignity; GMC Good practice in prescribing and managing medicines and devices

 

Further reading

• Drug misuse and dependence: UK guidelines on clinical management
• NICE technology appraisal on methadone and buprenorphine for the management of opioid dependence
• GMC Good practice in prescribing and managing medicines and devices

 

 

Unlock 32 more NHS interview questions

You have read the free questions. The full bank adds 32 premium questions for this role, each with a model answer, what the panel is assessing, key points and common mistakes.

One-off payment of £2.99 for 12 months' access. No subscription. Use the Unlock button at the top of this page.